266 related articles for article (PubMed ID: 27286639)
21. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
22. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
23. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
24. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
25. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
26. Facile Fabrication of Oxidation-Responsive Polymeric Nanoparticles for Effective Anticancer Drug Delivery.
Huang Y; Chen Q; Ma P; Song H; Ma X; Ma Y; Zhou X; Gou S; Xu Z; Chen J; Xiao B
Mol Pharm; 2019 Jan; 16(1):49-59. PubMed ID: 30485109
[TBL] [Abstract][Full Text] [Related]
27. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.
Margarida Cardoso M; Peça IN; Raposo CD; Petrova KT; Teresa Barros M; Gardner R; Bicho A
J Microencapsul; 2016 Jun; 33(4):315-22. PubMed ID: 27189857
[TBL] [Abstract][Full Text] [Related]
29. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
31. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
32. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
Kalam MA; Alshamsan A
Biomed Pharmacother; 2017 Oct; 94():402-411. PubMed ID: 28772219
[TBL] [Abstract][Full Text] [Related]
33. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
34. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
Vangara KK; Liu JL; Palakurthi S
Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
[TBL] [Abstract][Full Text] [Related]
36. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
37. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
38. Poly(lactide-co-glycolide) nanoparticles, layer by layer engineered for the sustainable delivery of antiTNF-α.
Romero G; Ochoteco O; Sanz DJ; Estrela-Lopis I; Donath E; Moya SE
Macromol Biosci; 2013 Jul; 13(7):903-12. PubMed ID: 23696518
[TBL] [Abstract][Full Text] [Related]
39. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
40. Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.
Zhang HY; Firempong CK; Wang YW; Xu WQ; Wang MM; Cao X; Zhu Y; Tong SS; Yu JN; Xu XM
Acta Pharmacol Sin; 2016 Jun; 37(6):834-44. PubMed ID: 27133301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
